| miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1 CL Lino Cardenas, IS Henaoui, E Courcot, C Roderburg, C Cauffiez, ... PLoS genetics 9 (2), e1003291, 2013 | 261 | 2013 |
| Increased circulating miR-21 levels are associated with kidney fibrosis F Glowacki, G Savary, V Gnemmi, D Buob, C Van der Hauwaert, ... PloS one 8 (2), e58014, 2013 | 233 | 2013 |
| Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10/CD13 double labeling C Van der Hauwaert, G Savary, V Gnemmi, F Glowacki, N Pottier, ... PloS one 8 (6), e66750, 2013 | 117 | 2013 |
| CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation F Glowacki, A Lionet, D Buob, M Labalette, D Allorge, F Provôt, M Hazzan, ... Nephrology Dialysis Transplantation 26 (9), 3046-3050, 2011 | 114 | 2011 |
| The long noncoding RNA DNM3OS is a reservoir of FibromiRs with major functions in lung fibroblast response to TGF-β and pulmonary fibrosis G Savary, E Dewaeles, S Diazzi, M Buscot, N Nottet, J Fassy, E Courcot, ... American journal of respiratory and critical care medicine 200 (2), 184-198, 2019 | 99 | 2019 |
| Identification of a Novel Splice‐site Mutation in the CYP1A2 Gene D Allorge, D Chevalier, JM Lo‐Guidice, C Cauffiez, F Suard, P Baumann, ... British journal of clinical pharmacology 56 (3), 341-344, 2003 | 96 | 2003 |
| MUC1 drives epithelial–mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter V Gnemmi, A Bouillez, K Gaudelot, B Hémon, B Ringot, N Pottier, ... Cancer letters 346 (2), 225-236, 2014 | 92 | 2014 |
| FibromiRs: translating molecular discoveries into new anti-fibrotic drugs N Pottier, C Cauffiez, M Perrais, P Barbry, B Mari Trends in pharmacological sciences 35 (3), 119-126, 2014 | 90 | 2014 |
| miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy MF Hennino, D Buob, C Van der Hauwaert, V Gnemmi, Z Jomaa, N Pottier, ... Scientific reports 6 (1), 27209, 2016 | 82 | 2016 |
| Characterisation of novel defective thiopurine S-methyltransferase allelic variants A Garat, C Cauffiez, N Renault, JM Lo-Guidice, D Allorge, D Chevalier, ... Biochemical pharmacology 76 (3), 404-415, 2008 | 76 | 2008 |
| Five novel natural allelic variants--951A> C, 1042G> A (D348N), 1156A> T (I386F), 1217G> A (C406Y) and 1291C> T (C431Y)--of the human CYP1A2 gene in a French Caucasian population D Chevalier, C Cauffiez, D Allorge, JM Lo-Guidice, M Lhermitte, JJ Lafitte, ... Human mutation 17 (4), 355, 2001 | 70 | 2001 |
| In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase R Hamdan-Khalil, D Allorge, JM Lo-Guidice, C Cauffiez, D Chevalier, ... Biochemical and biophysical research communications 309 (4), 1005-1010, 2003 | 68 | 2003 |
| Prevention of cisplatin-induced acute kidney injury: a systematic review and meta-analysis A Hamroun, R Lenain, JJ Bigna, E Speyer, L Bui, P Chamley, N Pottier, ... Drugs 79, 1567-1582, 2019 | 65 | 2019 |
| Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility C Cauffiez, JM Lo-Guidice, S Quaranta, D Allorge, D Chevalier, S Cenée, ... Biochemical and biophysical research communications 317 (2), 662-669, 2004 | 56 | 2004 |
| Xenobiotic metabolism and disposition in human lung: transcript profiling in non-tumoral and tumoral tissues J Leclerc, ECN Ngangue, C Cauffiez, D Allorge, N Pottier, JJ Lafitte, ... Biochimie 93 (6), 1012-1027, 2011 | 52 | 2011 |
| Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma K Gaudelot, JB Gibier, N Pottier, B Hémon, I Van Seuningen, F Glowacki, ... Tumor Biology 39 (7), 1010428317707372, 2017 | 49 | 2017 |
| Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in … F Glowacki, A Lionet, JP Hammelin, M Labalette, F Provôt, M Hazzan, ... Clinical pharmacokinetics 50, 451-459, 2011 | 49 | 2011 |
| Characterization of new mutations in the coding sequence and 5'-untranslated region of the human prostacyclin synthase gene (CYP8A1) D Chevalier, C Cauffiez, C Bernard, JM Lo-Guidice, D Allorge, F Fazio, ... Human genetics 108, 148-155, 2001 | 48 | 2001 |
| Evidence for a functional genetic polymorphism of the human thiosulfate sulfurtransferase (Rhodanese), a cyanide and H2S detoxification enzyme I Billaut-Laden, D Allorge, A Crunelle-Thibaut, E Rat, C Cauffiez, ... Toxicology 225 (1), 1-11, 2006 | 47 | 2006 |
| Knockout of receptor for advanced glycation end‐products attenuates age‐related renal lesions T Teissier, V Quersin, V Gnemmi, M Daroux, M Howsam, F Delguste, ... Aging Cell 18 (2), e12850, 2019 | 41 | 2019 |
Bernard MariDirecteur de Recherche CNRSVerified email at unice.fr
